These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10722424)

  • 1. National survey of extended-interval aminoglycoside dosing.
    Chuck SK; Raber SR; Rodvold KA; Areff D
    Clin Infect Dis; 2000 Mar; 30(3):433-9. PubMed ID: 10722424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single daily dosing of aminoglycosides--A community standard?
    Brown GH; Bertino JS; Rotschafer JC
    Clin Infect Dis; 2000 Mar; 30(3):440-1. PubMed ID: 10722425
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended interval aminoglycoside dosing: from concept to clinic.
    Maglio D; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2002 Apr; 19(4):341-8. PubMed ID: 11978505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-interval dosing of aminoglycosides.
    Blam ME; Hammer GS
    Mt Sinai J Med; 1997 Nov; 64(6):386-91. PubMed ID: 9364833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
    Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
    J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of an aminoglycoside pharmacokinetic dosing program.
    Schloemer JH; Zagozen JJ
    Am J Hosp Pharm; 1984 Nov; 41(11):2347-51. PubMed ID: 6507436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-interval aminoglycoside dosing in pediatrics.
    Jenh AM; Tamma PD; Milstone AM
    Pediatr Infect Dis J; 2011 Apr; 30(4):338-9. PubMed ID: 21407038
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidisciplinary protocol for determining aminoglycoside dosage.
    Lynch TJ; Possidente CJ; Cioffi WG; Hebert JC
    Am J Hosp Pharm; 1992 Jan; 49(1):109-15. PubMed ID: 1570850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring service.
    Pinilla J; Shafran S; Conly J
    Clin Invest Med; 1992 Feb; 15(1):8-17. PubMed ID: 1572110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.
    Asempa TE; Kuti JL; Seroogy JD; Komirenko AS; Nicolau DP
    Clin Ther; 2019 Aug; 41(8):1453-1462. PubMed ID: 31248681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminoglycoside treatment II: Dosage regimes at the departments of internal medicine in Denmark].
    Lund ES; Eliasen P; Wandall EP; Hansen EF; Lomholdt JD; Friis HM
    Ugeskr Laeger; 1997 Dec; 160(1):50-2. PubMed ID: 9446266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Hartford nomogram in trauma surgery patients.
    Finnell DL; Davis GA; Cropp CD; Ensom MH
    Ann Pharmacother; 1998 Apr; 32(4):417-21. PubMed ID: 9562135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of subtherapeutic aminoglycoside levels in trauma patients undergoing once-daily dosing.
    Toschlog EA; Blount KP; Rotondo MF; Sagraves SG; Bard MR; Schenarts PJ; Swanson M; Goettler CE
    J Trauma; 2003 Aug; 55(2):255-60; discussion 260-2. PubMed ID: 12913634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-interval gentamicin administration in malnourished children.
    Khan AM; Ahmed T; Alam NH; Chowdhury AK; Fuchs GJ
    J Trop Pediatr; 2006 Jun; 52(3):179-84. PubMed ID: 16126804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.
    Leong CL; Buising K; Richards M; Robertson M; Street A
    Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of software for the planning and adjusting of dosage. Application with aminoglycosides].
    Brouard A; Hubert I; Baud F; Clavier N; Galliot M; Bismuth C; Terriér JL
    Therapie; 1989; 44(5):331-6. PubMed ID: 2814914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of extended-interval gentamicin dosing for neonatal patients in developing countries.
    Darmstadt GL; Hossain MM; Jana AK; Saha SK; Choi Y; Sridhar S; Thomas N; Miller-Bell M; Edwards D; Aranda J; Willis J; Coffey P
    Pediatr Infect Dis J; 2007 Jun; 26(6):501-7. PubMed ID: 17529867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.